Curebound Challenges San Diego to Help Raise Vital Funding Amid Billions in Federal Grant Cuts that Threaten Cancer Research. Read More
Curebound is dedicated to accelerating cancer cures by funding the most promising, innovative research to collaborative teams from our six research partner institutions.
Curebound will award a total of 20 new grants across six institutional research partner organizations including UC San Diego Health, Salk Institute, Sanford Burnham Prebys, Rady Children’s, La Jolla Institute for Immunology, and Scripps Research.
“Everything that we raise today, 100% of donations, supports collaborative cancer research grants throughout the community.” Anne Marbarger, Curebound CEO.
Curebound launches all-new Curebound Cancer Challenge event and calls on individuals, corporations, and philanthropists to join together to support.
Twenty-seven-thousand San Diegans filled Petco Park on Friday, May 9 with snazzy suits, bedazzled jackets and sequined Dodgers gear for a one-night only show by musical superstar Elton John while fundraising for Curebound.
Elton John was given a returning hero’s welcome by the 27,000-strong audience. The concert raised $11.5 million for Curebound, the San Diego nonprofit that funds adult and pediatric cancer research.
The concert will raise money for cancer research, and mark one of musician's few major live events since retiring from the road in 2023.
The legendary singer-songwriter will perform May 9 at Petco Park, where he will headline the 2025 Concerts for Cures to raise funds for Curebound, whose previous benefit concerts here have featured Alicia Keys and Ed Sheeran.
Philanthropic organization has awarded $43 million in cancer research to date, awarding 142 study grants with one vision: cures in our lifetime.
$43 million invested in research for 23 types of cancer by Curebound so far; call to community during season of giving to help in fight against cancer
Music lover, car enthusiast, attorney, businessperson - Ralph Whitworth was well known in Rancho Sante Fe and throughout San Diego for his great talents and large personality.
Curebound launched its new Curebound Cancer Challenge today. An evolution of Curebound’s renowned Padres Pedal the Cause event
Curebound Catalyst Grants award up to $250,000 to early-stage companies to conduct innovative oncology-based research.
SAN DIEGO – Curebound is gaining momentum as it adds new initiatives to its funding of cancer research and clinical trials.
Research could lead to next-generation immunotherapy for head and neck cancer patients, and may have broad impact on treatments for other types of cancer.
Don’t expect a nine to five if you really want to make a difference. Usually, at nonprofits, you have to wear a lot of hats.
"Curebound funding was critical to expanding our pilot program into an NCI-funded clinical trial..."
Precision oncology aims to optimally select treatment for each patient with cancer by first identifying and subsequently targeting molecular defects in the patient's tumor.
Padres Pedal the Cause has raised $24+ million by mobilizing survivors, families, friends, doctors, scientists, corporate partners, and volunteers.
The Cure Prize challenge is to develop an innovation that will improve the standard of care for a typically deadly cancer with patient application in three-five years.
Dr. Paula Aristizabal, a research partner scientist at Rady Children’s Hospital, who also leads Curebound’s Cancer Equities committee as a member of the Scientific Advisory Board
Jonathan Schwartz, a father of a young cancer survivor, said “100% of the donations go towards collaborative research right here in San Diego. It is literally saving lives. She is living proof of it.”
In chart-topping English singer-songwriter Sheeran, Curebound has a headliner who is one of the biggest live-music attractions in the world.
Curebound ended the year by selecting 25 exceptional cancer research teams for a total commitment of $11.5 million. This extraordinary investment is made possible by the generosity of 13,443 who supported Curebound last year and we couldn’t be more grateful for your support.
Led by co-chairs Amy Koman and Fernanda Whitworth, Concert for Cures returns on Friday, October 20, bringing the San Diego community together for a night of hope.
“The first year I was diagnosed in 2021 is was only able to walk the 5K, but with the treatments I was able to run it last year. This year I am hoping to ride the 25 mile route.” Cancer fighter, Joseph Pangelinan.
Curebound is dedicated to accelerating cancer cures by funding the most promising, innovative research to collaborative teams from our six research partner institutions.
Curebound will award a total of 20 new grants across six institutional research partner organizations including UC San Diego Health, Salk Institute, Sanford Burnham Prebys, Rady Children’s, La Jolla Institute for Immunology, and Scripps Research.
“Everything that we raise today, 100% of donations, supports collaborative cancer research grants throughout the community.” Anne Marbarger, Curebound CEO.
Curebound launches all-new Curebound Cancer Challenge event and calls on individuals, corporations, and philanthropists to join together to support.
Twenty-seven-thousand San Diegans filled Petco Park on Friday, May 9 with snazzy suits, bedazzled jackets and sequined Dodgers gear for a one-night only show by musical superstar Elton John while fundraising for Curebound.
Elton John was given a returning hero’s welcome by the 27,000-strong audience. The concert raised $11.5 million for Curebound, the San Diego nonprofit that funds adult and pediatric cancer research.
The concert will raise money for cancer research, and mark one of musician's few major live events since retiring from the road in 2023.
The legendary singer-songwriter will perform May 9 at Petco Park, where he will headline the 2025 Concerts for Cures to raise funds for Curebound, whose previous benefit concerts here have featured Alicia Keys and Ed Sheeran.
Philanthropic organization has awarded $43 million in cancer research to date, awarding 142 study grants with one vision: cures in our lifetime.
$43 million invested in research for 23 types of cancer by Curebound so far; call to community during season of giving to help in fight against cancer
Music lover, car enthusiast, attorney, businessperson - Ralph Whitworth was well known in Rancho Sante Fe and throughout San Diego for his great talents and large personality.
Curebound launched its new Curebound Cancer Challenge today. An evolution of Curebound’s renowned Padres Pedal the Cause event
Curebound Catalyst Grants award up to $250,000 to early-stage companies to conduct innovative oncology-based research.
SAN DIEGO – Curebound is gaining momentum as it adds new initiatives to its funding of cancer research and clinical trials.
Research could lead to next-generation immunotherapy for head and neck cancer patients, and may have broad impact on treatments for other types of cancer.
Don’t expect a nine to five if you really want to make a difference. Usually, at nonprofits, you have to wear a lot of hats.
"Curebound funding was critical to expanding our pilot program into an NCI-funded clinical trial..."
Precision oncology aims to optimally select treatment for each patient with cancer by first identifying and subsequently targeting molecular defects in the patient's tumor.
Padres Pedal the Cause has raised $24+ million by mobilizing survivors, families, friends, doctors, scientists, corporate partners, and volunteers.
The Cure Prize challenge is to develop an innovation that will improve the standard of care for a typically deadly cancer with patient application in three-five years.
Dr. Paula Aristizabal, a research partner scientist at Rady Children’s Hospital, who also leads Curebound’s Cancer Equities committee as a member of the Scientific Advisory Board
Jonathan Schwartz, a father of a young cancer survivor, said “100% of the donations go towards collaborative research right here in San Diego. It is literally saving lives. She is living proof of it.”
In chart-topping English singer-songwriter Sheeran, Curebound has a headliner who is one of the biggest live-music attractions in the world.
Curebound ended the year by selecting 25 exceptional cancer research teams for a total commitment of $11.5 million. This extraordinary investment is made possible by the generosity of 13,443 who supported Curebound last year and we couldn’t be more grateful for your support.
Led by co-chairs Amy Koman and Fernanda Whitworth, Concert for Cures returns on Friday, October 20, bringing the San Diego community together for a night of hope.
“The first year I was diagnosed in 2021 is was only able to walk the 5K, but with the treatments I was able to run it last year. This year I am hoping to ride the 25 mile route.” Cancer fighter, Joseph Pangelinan.
Curebound is dedicated to accelerating cancer cures by funding the most promising, innovative research to collaborative teams from our six research partner institutions.
Curebound will award a total of 20 new grants across six institutional research partner organizations including UC San Diego Health, Salk Institute, Sanford Burnham Prebys, Rady Children’s, La Jolla Institute for Immunology, and Scripps Research.
“Everything that we raise today, 100% of donations, supports collaborative cancer research grants throughout the community.” Anne Marbarger, Curebound CEO.
Invested in cancer research
Innovative research grants underway
Exploration of 23 different types of adult and pediatric cancer
New or expanded clinical trials initiated, impacting approximately 1504 patients
Peer reviewed publications
New companies formed
56 collaborative grants have gone on to receive $139M in follow-on funding
Top research institutions working in partnership
VISION
cures in our lifetime
Curebound advances how we can better prevent, treat, and ultimately find cures for cancer. We are guided by three core principles:
Curebound is founded with the deep-seated belief that cures are possible; that cancer is curable. With the knowledge that each small finding leads to a larger discovery and then one day, a breakthrough. Curebound will accelerate the speed at which we transform research into cures.
At Curebound, collaboration is central to everything we do. Our funding model creates collaboration across multiple disciplines among the top research institution in San Diego. We provide early phase, follow-on and clinical trial funding to specialized research teams that bring together physician scientists, clinical researchers, and basic science researchers to work in partnership on specific challenges in cancer research.
In some way, this cause will touch all of our lives: every person, family and community. Curebound serves all of San Diego’s diverse communities, united with one vision: cures in our lifetime. Through the power of collaboration and the spirit of community, we will ensure that the next generation doesn’t hear the words “you have cancer” in the way we do today.
Cancer is relentless. So are we.
Cancer affects all of us. Every person, every family, every community. Learn more about how you can get involved with Curebound and accelerate research into cures.
Sign up to receive more information and updates from Curebound.